Insider filing · SVRA
David L Lowrance
Chief Financial Officer
profile →
Savara Inc.
SVRA · Healthcare · 5 filings in 24 months
ticker →
David L Lowrance sold $2.2M of Savara (SVRA)
Executed Jun 22, disclosed Jun 22, the same day.
Value, as filed
$2.2M
394,528 sh × $5.68
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 22
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DLDavid L Lowrance (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Savara Inc. (SVRA). The largest single filing was $2.2M of SVRA (394,528 sh × $5.68, as filed), executed Jun 22.
The name
SVRAHealthcare · Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→